# Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care Unit

> **NCT01836224** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 84 (actual)

## Conditions studied

- Cirrhosis With Septic Shock

## Interventions

- **DRUG:** Terlipressin
- **DRUG:** Noradrenaline

## Key facts

- **NCT ID:** NCT01836224
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2016-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01836224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01836224, "Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care Unit". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01836224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*